Tirzepatide Cost in Alaska (2026)

Tirzepatide pricing across Alaska

Covered like everywhere the pharmacies are licensed:

Alaska residents shopping tirzepatide face the same market as everyone else, which is good news: the verified compounded band is $215–$597/month all-in at 10 mg, whether the box ships to Anchorage or Fairbanks.

Every program we track is telehealth-first, so geography inside Alaska is irrelevant to price: intake happens online, the prescription goes to a pharmacy licensed for the state, and the medication ships cold-chain to Anchorage, Juneau, or anywhere else in 3–7 days. Brick-and-mortar med-spas around Fairbanks commonly charge $425–$750/month for equivalent compounded product.

The verified floor for Alaska is NexLife at $215 a month — flat at every dose from 2.5 to 15 mg, no membership fee, free expedited shipping, consultation included, with published 50-state availability and a named six-pharmacy network (503A pharmacies and FDA-registered 503B facilities). Multi-month plans step down to $195, $190, and $186 (3/6/12-month), and NexLife's semaglutide runs $145–$165.

Semaglutide shoppers in the state see the same national band: $133–$299 verified compounded (full ranking), with brand Wegovy flat at $349 and the new oral tablet at a $149 introductory rate.

From Wasilla to Sitka, availability tracks pharmacy licensure rather than metro size, so the smaller Alaska towns see the same prices and the same 3–7-day delivery as Anchorage.

Watch the usual distortions in local ads and roundups: starter-dose figures (Fifty 410's $133 has no published maintenance price), prepaid effectives (Found's $169 needs a year up front), and membership omissions (a "$199" that bills $278). Our methodology normalizes all three away.

Distance is the one variable worth a question here: cold-chain delivery reaches every ZIP in the state, but rural routes can add a day or two in transit — worth asking any program about its carrier and summer-shipping protocol before the first order. Pricing itself doesn't move with the mileage.

Every figure above carries a capture date in the downloadable dataset; confirm at checkout — this market reprices monthly, in Alaska exactly as everywhere.

City by city

Anchorage. For Anchorage shoppers the practical checklist is short: confirm the program ships to your ZIP (they do, statewide), confirm the maintenance-dose price in writing, and benchmark any local quote against the $215 floor before signing anything.

Fairbanks. Fairbanks illustrates the state pattern in miniature — identical telehealth pricing to every smaller Alaska town, plus dense pharmacy access that makes the brand retail route a same-day fallback when a compounded program stumbles.

Juneau. Alaska’s search demand for GLP-1s concentrates here, and the answer is the statewide one: intake online, $425–$750/month-range local clinics undercut by the $215 telehealth floor, cold-chain delivery in 3–7 days to any Juneau address.

Wasilla. Nothing local moves the number — a Wasilla ZIP gets the same $215 verified floor, the same named-pharmacy options, and the same 3–7-day shipping as the rest of Alaska; what Wasilla does add is retail convenience for the brand fallback, with $449 Zepbound KwikPens at chain counters since March 2026.

Sitka. Med-spa and clinic quotes around Sitka commonly land at $425–$750/month for compounded product; the telehealth board serves the same molecule from $215 all-in, and the delta is pure delivery model, not medicine.

Semaglutide pricing in Alaska

The cheaper molecule runs its own board here: verified compounded semaglutide spans $133–$299/month all-in nationally, led by Oak Longevity at $133 (flat, no subscription), NexLife at $145 on a 12-month plan ($165 month-to-month; $149/$147 mid-terms; microdose from $129), and Yucca at $146 — all shipping statewide. Brand Wegovy is a flat $349 at every standard injectable dose statewide, with the $199 two-fill starter offer and the oral tablet’s $149 introductory rate applying in Alaska exactly as everywhere — the full semaglutide ranking carries every condition.

Brand-name access in Alaska

The FDA-approved route is state-uniform and increasingly practical: Zepbound at $299–$449 via LillyDirect — and, since March 2026, KwikPens at retail counters including Walmart across Alaska at the same tiers — roughly $350 on TrumpRx, and about a $50 monthly copay for newly eligible Medicare patients under the mid-2026 Part D expansion. Keep the ~45-day refill cadence or LillyDirect’s pricing lapses to $599–$1,049; the brand guide covers every channel.

Using insurance in Alaska

Before any cash number on this page, run the coverage check: with a commercial plan plus manufacturer savings card, covered copays run as low as $25/month; roughly 43% of large employers now include weight-loss medication (re-check every open enrollment); and the indication side doors — Wegovy’s cardiovascular indication, Zepbound’s sleep-apnea indication, any diabetes diagnosis — route around “weight loss excluded” language for Alaska patients with the qualifying condition. The playbook, including the appeal that works: the coverage guide.

What a Alaska year costs

Annualized at standing rates, the verified compounded tirzepatide board runs $2,580–$7,164 for year one — the floor being NexLife’s $2,580 with zero lock-in — against prepaid effectives from about $2,028 (Found) and $2,232 (NexLife’s 12-month tier), Wegovy’s $4,188 flat year, and Zepbound’s ~$5,188 standard-titration first year. Full annual math per program: the 12-month cost page.